IMMUNEONCO-B

1541
2.8800.52% ( +0.015 )
Delay Closed: Nov 17, 16:08:15

Shareholders

All Shareholders

Shareholder Type

  • Public and others63.70%
  • Individuals & Insiders16.41%
  • ESOPs10.64%
  • VC/PE firms8.47%
  • Institutions0.78%

Major Shareholders

Major Shareholders Latest
Shareholder
Wenzhi TianFounder, CEO, Chief Scientific Officer & Chairman of the Board
16.41%70.48M0.09%+50.00K
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. , ESOP
10.64%45.70M0.05%+0
Shanghai Yongkan Investment Management Co., Ltd.
8.47%36.39M0.04%+0
GF Fund Management Co., Ltd.
0.76%3.28M<0.01%+0
Fullgoal Fund Management Co. Ltd.
0.02%88.60K<0.01%+0
Dimensional Fund Advisors LP
0.00%0.00<0.01%-18.80K
State Street Investment Management
0.00%0.000.22%-939.20K